HAVACS participants were more likely to have had an AIDS-defining event (whether including or excluding CD4<200) prior to HAART initiation and were more likely to be hepatitis C and hepatitis B co-infected at HAART initiation (all p<0.0001). The gene discussed is CD4; the disease is hepatitis A virus infection.